Who has invested in MEDFAR Clinical Solutions?

Investissement Quebec are named among the investors backing MEDFAR Clinical Solutions.

MEDFAR Clinical Solutions Funding: $55M Raised, Series C

MEDFAR Clinical Solutions funding overview

MEDFAR Clinical Solutions is based in Montreal, Canada. MEDFAR Clinical Solutions has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in April 2023. The round record for MEDFAR Clinical Solutions runs through 2023; nothing later has been disclosed. Investors on record include Investissement Quebec.

MEDFAR Clinical Solutions at a glance

Total raised: $55M
Latest round: Series C
Latest round date: April 2023
Headquarters: Montreal, Canada
Notable investors: Investissement Quebec

Frequently asked about MEDFAR Clinical Solutions funding

How much has MEDFAR Clinical Solutions raised?: MEDFAR Clinical Solutions has raised $55M in total disclosed funding across the rounds on record.
Who has invested in MEDFAR Clinical Solutions?: Investissement Quebec are named among the investors backing MEDFAR Clinical Solutions.
What was the latest MEDFAR Clinical Solutions funding round?: The most recent disclosed round is a Series C, announced in April 2023.
Where is MEDFAR Clinical Solutions based?: MEDFAR Clinical Solutions is based in Montreal, Canada.
When did MEDFAR Clinical Solutions last raise?: The last disclosed MEDFAR Clinical Solutions round closed in April 2023 at Series C.

MEDFAR Clinical Solutions totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Montreal below to benchmark round size and investor mix.

MEDFAR Clinical Solutions Funding: $55M Raised, Series C

MEDFAR Clinical Solutions funding overview

MEDFAR Clinical Solutions at a glance

Frequently asked about MEDFAR Clinical Solutions funding

Companies related to MEDFAR Clinical Solutions (19)

Browse related funding lists (3)